Anavex Life Sciences Files Q2 2025 10-Q
Ticker: AVXL · Form: 10-Q · Filed: May 13, 2025 · CIK: 1314052
| Field | Detail |
|---|---|
| Company | Anavex Life Sciences Corp. (AVXL) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, financials
TL;DR
Anavex Life Sciences filed their Q2 2025 10-Q. Check financials.
AI Summary
Anavex Life Sciences Corp. filed its 10-Q for the period ending March 31, 2025. The company, previously known as Thrifty Printing Inc., is focused on biological products. Their fiscal year ends on September 30th, and this filing covers the second quarter of their 2025 fiscal year.
Why It Matters
This filing provides an update on Anavex Life Sciences' financial performance and operational status for the second quarter of fiscal year 2025, which is crucial for investors to assess the company's progress.
Risk Assessment
Risk Level: medium — As a biotech company, Anavex Life Sciences is subject to inherent risks related to drug development, clinical trials, and regulatory approvals.
Key Numbers
- Q2 2025 — Fiscal Quarter (Reporting period ending March 31, 2025)
- 0930 — Fiscal Year End (Company's fiscal year concludes on September 30th)
Key Players & Entities
- ANAVEX LIFE SCIENCES CORP. (company) — Filer
- Thrifty Printing Inc. (company) — Former company name
- 20250331 (date) — Period of report
- 20250513 (date) — Filing date
- 0001314052 (company) — Central Index Key
FAQ
What is the primary business of Anavex Life Sciences Corp.?
Anavex Life Sciences Corp. is primarily involved in biological products, specifically in the area of biological products (no diagnostic substances).
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025, which corresponds to the second quarter of their fiscal year 2025.
When was Anavex Life Sciences Corp. formerly known as?
Anavex Life Sciences Corp. was formerly known as Thrifty Printing Inc.
What is the company's fiscal year end date?
The company's fiscal year end date is September 30th.
What is the Central Index Key (CIK) for Anavex Life Sciences Corp.?
The Central Index Key (CIK) for Anavex Life Sciences Corp. is 0001314052.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding ANAVEX LIFE SCIENCES CORP. (AVXL).